Kameoka M - Search Results

1

Intracellular glutathione as a possible direct blocker of HIV type 1 reverse transcription.

Kameoka M, Okada Y, Tobiume M, Kimura T, Ikuta K. Kameoka M, et al. AIDS Res Hum Retroviruses. 1996 Nov 20;12(17):1635-8. doi: 10.1089/aid.1996.12.1635. AIDS Res Hum Retroviruses. 1996. PMID: 8947299

2

Viral activation from latency during retrodifferentiation of U937 cells exposed to phorbol ester followed by infection with human immunodeficiency virus type 1.

Okada Y, Kimura T, Kameoka M, Kishi M, Azuma I, Ikuta K. Okada Y, et al. Among authors: kameoka m. Immunopharmacology. 1995 Jun;30(1):27-39. doi: 10.1016/0162-3109(95)98646-k. Immunopharmacology. 1995. PMID: 7591711

3

High susceptibility of U937-derived subclones to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation.

Kameoka M, Kimura T, Okada Y, Nakaya T, Kishi M, Ikuta K. Kameoka M, et al. Immunopharmacology. 1995 Jun;30(1):89-101. doi: 10.1016/0162-3109(95)00012-i. Immunopharmacology. 1995. PMID: 7591717

4

Extracellular Nef protein regulates productive HIV-1 infection from latency.

Fujinaga K, Zhong Q, Nakaya T, Kameoka M, Meguro T, Yamada K, Ikuta K. Fujinaga K, et al. Among authors: kameoka m. J Immunol. 1995 Dec 1;155(11):5289-98. J Immunol. 1995. PMID: 7594542

5

Poly(ADP-ribose) polymerase activity in various U937 cell subclones with different susceptibility to HIV-1 infection: its dramatic decrease following persistent virus infection.

Tanaka Y, Yoshihara K, Kojima K, Itaya A, Kameoka M, Ikuta K, Kamiya T. Tanaka Y, et al. Among authors: kameoka m. Biochem Biophys Res Commun. 1995 Aug 4;213(1):161-8. doi: 10.1006/bbrc.1995.2111. Biochem Biophys Res Commun. 1995. PMID: 7639731

6

In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24.

Nishino Y, Kameoka M, Okada Y, Zhong Q, Kimura T, Azuma I, Ikuta K. Nishino Y, et al. Among authors: kameoka m. Vaccine. 1994 May;12(6):485-91. doi: 10.1016/0264-410x(94)90304-2. Vaccine. 1994. PMID: 7913566

7

The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells.

Otake K, Fujii Y, Nakaya T, Nishino Y, Zhong Q, Fujinaga K, Kameoka M, Ohki K, Ikuta K. Otake K, et al. Among authors: kameoka m. J Immunol. 1994 Dec 15;153(12):5826-37. J Immunol. 1994. PMID: 7989778

8

Superoxide enhances the spread of HIV-1 infection by cell-to-cell transmission.

Kameoka M, Kimura T, Ikuta K. Kameoka M, et al. FEBS Lett. 1993 Sep 27;331(1-2):182-6. doi: 10.1016/0014-5793(93)80322-l. FEBS Lett. 1993. PMID: 8104823 Free article.

9

Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop.

Kameoka M, Nishino Y, Matsuo K, Ohara N, Kimura T, Yamazaki A, Yamada T, Ikuta K. Kameoka M, et al. Vaccine. 1994 Feb;12(2):153-8. doi: 10.1016/0264-410x(94)90054-x. Vaccine. 1994. PMID: 8147098

10

Amplification of superoxide anion generation in phagocytic cells by HIV-1 infection.

Kimura T, Kameoka M, Ikuta K. Kimura T, et al. Among authors: kameoka m. FEBS Lett. 1993 Jul 12;326(1-3):232-6. doi: 10.1016/0014-5793(93)81797-4. FEBS Lett. 1993. PMID: 8391999 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters